Speaker illustration

Mr Maxim Grymonprez

Ghent University, Ghent (Belgium)

Member of:

European Society of Cardiology
European Heart Rythm Association

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: a nationwide cohort study

Event: ESC Congress 2022

Topic: Anticoagulants

Session: Anticoagulant therapy: real world use and clinical challenges


Impact of P-glycoprotein and/or CYP3A4-interacting drugs on the risk-benefit profile of NOACs in patients with atrial fibrillation: a meta-analysis

Event: EHRA 2022

Topic: Oral Anticoagulation

Session: Moderated ePosters - How to optimise stroke prevention in atrial fibrillation


ESC 365 is supported by

logo Novo Nordisk